Valuation (29%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 284.43 | N/A |
| PEG Ratio (TTM) | -6.16 | N/A |
| P/S Ratio (TTM) | 2.19 | N/A |
| P/B Ratio (TTM) | 2.25 | N/A |
| P/FCF Ratio (TTM) | -185.61 | N/A |
| Price to 5YR AVG Earnings Ratio | -71.59 | N/A |
| Price to 5YR AVG FCF Ratio | 34.63 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.37% | N/A |
| ROE (TTM) | 0.80% | N/A |
| Net Profit Margin (TTM) | 0.77% | N/A |
| ROIC 5YR AVG | 2.46% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 60.65% | 33.73% | 54.76% |
| Revenue | -0.19% | -8.43% | -4.96% |
| Net Income | 62.18% | 31.50% | 53.05% |
| Cash Flow | 13.50% | 40.21% | 21.64% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.20 | N/A |
| Quick Ratio (TTM) | 1.20 | N/A |
| D/E Ratio (TTM) | 0.58 | N/A |
| Interest Coverage (TTM) | 2.15 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.11 | N/A |
| LTL to 5YR AVG FCF | 9.89 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.22% | N/A |